Geou-Yarh Liou

Clark Atlanta University

$2,856,018

Attributed

$2,856,018

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY2021–25

$2M$1.5M$1M$500K$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,856,018 · 2

By mechanism

U54$1,585,518 · 1

SC1$1,270,500 · 1

Top collaborators

No co-investigators on record.

Most similar at Clark Atlanta University

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Incidence”

Yunda Huang · Fred Hutchinson Cancer Center$53,742,512
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
Susan Abushakra · Alzheon, Inc.$47,265,244
Julie Ake · National Institute Of Allergy And Infectious Diseases$39,792,120
Christopher Barnaby Nelson · University Of Melbourne$27,954,628
Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420

Research focus

IncidenceSignal TransductionCancer EtiologyFutureCessation Of LifeDeath RateEarly DiagnosisEarly InterventionEventDigit StructureAnimal ModelAcinar CellEarly Detection BiomarkersBackDiagnosisDrug TargetingBiomarker IdentificationChemotherapy3-DimensionalCcl15 GeneCancer CellCancer DiagnosisAcinus Organ ComponentCells

Grant awards (6)

RESEARCH CAPACITY CORE$490,594

U54 · FY2025 · MD · contact PI

RESEARCH CAPACITY CORE$1,094,924

U54 · FY2024 · MD · contact PI

Dissecting mechanisms of tumor initiation via immunomodulation$308,000

SC1 · FY2024 · GM · contact PI

Dissecting mechanisms of tumor initiation via immunomodulation$346,500

SC1 · FY2023 · GM · contact PI

Dissecting mechanisms of tumor initiation via immunomodulation$269,500

SC1 · FY2022 · GM · contact PI

Dissecting mechanisms of tumor initiation via immunomodulation$346,500

SC1 · FY2021 · GM · contact PI